Y. Sugi et J. Lough, ANTERIOR ENDODERM IS A SPECIFIC EFFECTOR OF TERMINAL CARDIAC MYOCYTE DIFFERENTIATION OF CELLS FROM THE EMBRYONIC HEART FORMING REGION, Developmental dynamics, 200(2), 1994, pp. 155-162
The ability of anterior lateral plate mesoderm cells in the heart-form
ing region (HFR) of stage 6 chicken embryos to respond to cardiogenic
stimuli from cells in adjacent germ layers has been investigated using
explants cultured under defined conditions. Two types of explantation
were evaluated: those in which two germ layers were explanted in cont
iguity, and those in which germ layers were isolated and cocultured. T
wo parameters-contractility and expression of sarcomeric alpha-actin-w
ere monitored to evaluate the terminal differentiation of cardiac myoc
ytes. Contiguously explanted anterior endoderm/mesoderm became multila
yered and underwent terminal differentiation within 2 days. By contras
t, although contiguous anterior ectoderm/mesoderm or posterior endoder
m/mesoderm co-explants also became multilayered, these explants did no
t differentiate, up to 5 days. To ascertain the cardiogenic potential
of cells from different regions of the embryo, individual germ layers
were isolated and co-cultured by placing the explants in separate area
s of the culture chamber. These determinations demonstrated that anter
ior, but not posterior, endoderm effected differentiation of anterior
mesoderm. As before, mesoderm in both types of co-culture survived and
became multilayered; by contrast, mesoderm did not survive when cultu
red in isolation. These experiments provide evidence that anterior end
oderm regulates the terminal differentiation, as opposed to growth, of
presumptive cardiac myocytes in mesoderm cells from the anterior late
ral plate. Finally, anterior endoderm was co-cultured with mesoderm fr
om the posterior half of the embryo, which does not contain an HFR. Th
e failure of these co-cultured explants to differentiate infers that p
re-cardiac myoblasts in stage 6 anterior mesoderm are previously speci
fied to respond to the terminal cardiogenic effects of endoderm. (C) 1
994 Wiley-Liss, Inc.